GACC Registry Single Window e-Service | Home | GACC | FAQs | Login | Registry Signup | Contact us |

GACC Registration Single Window
-  e-Service Center  -

Cost & Time for Drug China NMPA Register(Import Drug Licence (IDL) approval Phase)

Tags: | NMPA | Pharmaceuticals | Drug | 药监局 | 医药品 | 药品 |


Phase C.         Import Drug Licence (IDL) approval Phase





Work content


FDA Application Dossiers Draft, Edit, Compile , Pre-review and Official Submitit

contact us

1-3 months

1.    Compile clinical trial report and relevant clinical study dossiers according to the results of clinical trial

2.    Modify quality standards of product and other application dossiers to be modified according to the results of NICPBP examination.

3. Compile 32 application dossiers required for CFDA IDL.

4. Formal submission to CFDA


CDE Technical Evaluation & Follow up

contact us

6- 10


( Time is controlled by CDE ),

1Follow up drug technical evaluation in CDE, communicate with reviewing technological expert, and solve problems met during review at any time.

2Promptly submit supplemental dossiers required by CDE if technical dossiers need to be corrected.


Import Drug Licence CFDA Approval & Follow up

contact us

1-2 Months  (Time controlled by  CFDA )

Communicate with relevant officers, promote rapid and successful pass of Import Drug Licence CFDA Approval.



contact us

 10-14 months



1 Abbreviations define: CFDA: China Food & Drug Administration ; CDE: Center for Drug Evaluation , NICPBP :National Institute for the Control of Pharmaceutical & Biological Products

2The time of CFDA review , NICPBP products testing, CDE technical Evaluation etc, can not be controlled by the agent, so,any time be postponed cause by such step, will not be included in the time commitment appraisal of the agent service.